National and Kapodistrian University of Athens
Μελέτη της μοριακής διαταραχής του φαινοτύπου της οικογενούς υπερχοληστερολαιμίας (FH) στον ελληνικό πληθυσμό: γονίδια LDL-R, APOB-100, PSCK9, και ARH
Abstract
dc:descriptionAtherosclerosis constitutes the fundamental cause of cardiovascular diseases, such as infarction, angina pectoris and vasal cerebral episodes. Hypercholesterolemia is the main cause for the 30-50% cardiovascular diseases, which constitute the main cause of death of young in most developed countries and are accountable for up to 50% of deaths. The illness begins from childhood and develops during adulthood. Many studies have shown that the risk factors that contribute to the development of atherosclerosis are distinguished in lipidaimic and not lipidaimic factors. Lipidaemic risk factors that contribute to the development of atherosclerosis are: increased total cholesterol (TC), increased levels of triglycerides (TG), low density cholesterol (HDL-C), low density lipoprotein (LDL-C) Familial hypercholesterolemia is a common disease that is presented in 1% of adults and is considered to be responsible for 10% of early events of illness. Children with inherited defects in lipid metabolism and particularly in the gene encoding the LDL receptor are characterised as heterozygotes with a frequency of 1:500. They present levels of total cholesterol TC > 200 mg/dl and develop cardiovascular diseases in the adult life. Homozygous children are presented with a frequency of 1:1.000.000. The levels of total cholesterol range from 500 to 2000 mg/dl while clinically present tendon xanthomas up to the age of 5 years, corneal arcus as well as severe damage of coronary arteries up to the age of 20 years. Aim of my work is to study of Greek patients expressing the phenotype of familial hypercholesterolemia, with positive family history. Exclusion of any mutation in the LDL-R gene will lead to the analysis of the ApoB-100 gene for the 3 most frequent mutations, R3500Q, R3500W, and R3531C In the case that the study of ApoB100 mutations is negative then the third phase of the study was performed on the new gene, PCSK9 follows. The patients with phenotypical ADH and with a positive family history and no mutations in the genes of LDL-R and ApoB-100, will constitute our inquiring material for likely mutations in PCSK9 gene, for the first time in Greece. The detection of possible mutations in this gene will be done by PCR and sequencing. Firstly, we will focus on the four most frequent mutations in the gene and afterwards, if no mutations are found, we will amplify all the exons by PCR and after sequencing of the whole gene our interest will be focused on new mutations In addition, studies have shown that from the 311 polymorphisms of PCSK9 detected up to date some are associated with high and others with low levels of lipids, a fact that can characterize these genetic indicators as cardioprotective or not. So we will study 9 polymorphisms of the PCSK9 gene. For the first time in Greece the R3500Q mutation apoB100 gene was detected in a child while mutations in PCSK9 do not constitute a fundamental cause of familial hypercholesterolemia in Greece. The identification of polymorphisms showed that indeed the A53V, rs 615563, rs 644000 are associated with levels of lipids, A53V is associated with high levels of HDLc and can be considered as cardioprotective.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Koniari, Eleni
- Κόνιαρη, Ελένη
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/24255